- A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells
- A pilot clinical study of D9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
- Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
- Antiangiogenic activity of the endocannabinoid anandamide- Correlation to its tumor-suppressor efficacy
- Anticancer mechanisms of cannabinoids
- Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells
- Anti-tumoral action of cannabinoids- Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
- Anti-tumoral action of cannabinoids on hepatocellular carcinoma- role of AMPK-dependent activation of autophagy
- Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
- Antitumorigenic Effects of Cannabinoids beyond Apoptosis
- Cannabidiol (CBD) Priming Enhances Cisplatin Killing Of Cancer Cells
- Cannabidiol Enhances the Inhibitory Effects of D9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
- Cannabidiol as potential anticancer drug
- Cannabidiol Inhibits Cancer Cell Invasion Via Upregulation Of Tissue Inhibitor Of Matrix Metalloproteinases-1
- Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma–Associated Herpesvirus Infected Endothelium
- Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
- Cannabinoid-associated cell death mechanisms in tumor models (Review)
- Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma
- Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells
- Cannabinoid receptor ligands as potential anticancer agents – high hopes for new therapies
- Cannabinoid Receptor-Mediated Apoptosis Induced by R()-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma
- Cannabinoid receptors as novel targets for the treatment of melanoma
- Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
- Cannabinoids and Cancer
- Cannabinoids and cancer- pros and cons of an antitumour strategy
- Cannabinoids and ceramide- Two lipids acting hand-by-hand
- Cannabinoids and omega-3-6 endocannabinoids as cell death and anticancer modulators
- Cannabinoids as therapeutic agents in cancer- current status and future implications
- Cannabinoids, Endocannabinoids and Cancer
- Cannabinoids for Cancer Treatment- Progress and Promise
- Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
- Cannabinoids- potential antitumoral agents
- Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase-Protein Kinase B Pathway
- Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
- Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells
- Cannabis and Cannabinoids (PDQ®) – National Cancer Institute
- Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation
- Cannabis in Cancer Care
- CBD inhibits angiogenesis by multiple mechanisms
- Ceramide- a new second messenger of cannabinoid action
- Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions
- COX-2 and PPAR-g Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
- Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
- Differential role of cannabinoids in the pathogenesis of skin cancer
- Endocannabinoids and Cancer
- Endocannabinoids and fatty acid amides in cancer inflammation and related disorders
- Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (Review)
- Endocannabinoids as Guardians of Metastasis
- Endocannabinoids in endocrine and related tumours
- Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules
- Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
- Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress- involvement of cannabinoid axis in liver cancer cells
- Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma
- Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma- Growth inhibition by receptor activation
- High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma
- Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
- In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma
- Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism
- Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1
- Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
- Inhibition of tumor angiogenesis by cannabinoids
- Integrating cannabis into clinical cancer care
- Involvement of PPARc in the antitumoral action of cannabinoids on hepatocellular carcinoma
- Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
- Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers- Results of a Population-Based Case-Control Study
- Medical marijuana for cancer
- Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
- Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo- pro-apoptotic effects and underlying mechanisms
- Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism
- Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2
- Preparation and characterisation of biodegradable microparticles filled with THC and their antitumor efficacy on cancer cell lines
- Proapoptotic effect of endocannabinoids in prostate cancer cells
- Receptor-dependent and receptor-independent endocannabinoid signaling- A therapeutic target for regulation of cancer growth
- Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
- Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
- Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
- The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
- The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway
- The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2
- The endocannabinoid system and cancer- therapeutic implication
- The endocannabinoid system in cancer- Potential therapeutic target
- The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
- The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas
- The potential relevance of the endocannabinoid, 2- arachidonoylglycerol, in diffuse large B-cell lymphoma
- The role of cannabinoids in prostate cancer- Basic science perspective and potential clinical applications
- The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells
- The use of cannabinoids as anticancer agents
- Towards the use of cannabinoids as antitumour agents
- United States patent application publication for phytocannabinoids in the treatment of cancer
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.